JSPRライブシグナル | Getagraph.comで利益を最大化

売る 115074 min ago

@ $17.42

発行日: 10 2月 2024 @ 03:49

リターン: 26.25%

前回のシグナル: 2月 9 - 01:44

前回のシグナル: 買う

リターン: 5.05 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:11):

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...

Stats
本日の出来高	6 997.00
平均出来高	116 382
時価総額	331.73M
EPS	$0 ( 2024-03-13 )
次の収益日	( $-1.200 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.360
ATR14	$0.103 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Mahal Jeetinder Singh	Buy	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Sell	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Buy	900	Stock Option (right to buy)
2024-02-15	Martell Ron	Buy	100 000	Stock Option (right to buy)
2024-02-15	Mahal Jeetinder Singh	Buy	40 000	Stock Option (right to buy)

INSIDER POWER
91.96
Last 82 transactions
Buy: 17 940 158 \| Sell: 1 631 987

ボリューム相関

長: 0.00 (neutral)

短: -0.84 (strong negative)

Signal:(84.096) Be Aware. Possible trading coming up! (swing)

Jasper Therapeutics, Inc. 相関

10 最も正の相関
SCR	0.947
PAIC	0.946
SRRA	0.928
SVAC	0.92
CMPO	0.915
ICON	0.912
TLGT	0.91
PAE	0.908
KIN	0.908
CRVL	0.907

10 最も負の相関
NETE	-0.947
LCAP	-0.939
VTIP	-0.924
AMRB	-0.915
OP	-0.901
RAVN	-0.899
MMAC	-0.898
NAKD	-0.896
NRBO	-0.896
PCSA	-0.895

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Jasper Therapeutics, Inc. 相関 - 通貨/商品

-0.65
( moderate negative )

-0.51
( weak negative )

0.00
( neutral )

-0.41
( neutral )

0.12
( neutral )

0.60
( weak )

Jasper Therapeutics, Inc. 財務諸表

Annual	2023
収益:	$0
総利益:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2023
収益:	$0
総利益:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2022
収益:	$0
総利益:	$-1.31M (0.00 %)
EPS:	$-6.63

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-2.69

Financial Reports:

No articles found.

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.